Download full report with analyst certification and important disclosures
Jun 3 2024, 07:10 IST/BST
hVIVO has signed an important new contract to initiate an Omicron characterisation study. Omicron is a variant of COVID-19. The study will utilise its new quarantine facilities in Canary Wharf. Depending on the success of this and regulatory approvals this could lead to multiple Omicron human challenge trials.
Jun 3 2024, 07:10 IST/BST